NXGL nexgel.com: Nilai perusahaan marang pendapatan

Simbol resmi perusahaan NEXGEL (NXGL)

Is it worth investing in NEXGEL, Inc. (NXGL), whose revenues rely on the regular sale of consumables to clinics? The EV/Revenue ratio provides the answer: the metric's value is 1613.32. The trend of this indicator reflects market expectations, where growth signals development and sharp peaks suggest a correction. The business remains crisis-resilient due to stable hospital demand and the implementation of innovative polymers for wound healing.

nexgel.com (NXGL): Rasio nilai perusahaan marang pendapatan saka 23.11.2025 nganti 20.11.2026

NXGL (NEXGEL Inc): rincian analitis lan laporan miturut indikator

- kuotasi saiki lan rata-rata prakiraan nilai:
- data kapitalisasi saham perusahaan:
Analisis wiwitan perusahaan:NEXGEL, Inc., NXGL
Produk sing diprodhuksi NEXGEL, Inc

To identify fundamental sector leaders, it is critical to evaluate enterprise value including net debt relative to revenue, which eliminates the impact of debt load on investment attractiveness. The current value of 1613.32 reflects the market value of NEXGEL, Inc. (NXGL) innovations in transdermal drug delivery, allowing the enterprise value-to-revenue ratio to determine the resilience of high-tech R&D leadership against market volatility.

Analisis pesaing NEXGEL, Inc.

ISRG - Multiplikator EV/Sales|DHR: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan BD (BDX)|Rasio nilai perusahaan marang pendapatan STERIS plc|Rasio nilai perusahaan marang pendapatan WST (West Pharmaceutical Services)|Nilai perusahaan marang pendapatan BAX (Baxter Corp)|Masimo - Rasio nilai perusahaan marang pendapatan|Stevanato Group S.p.A. - Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Teleflex Inc (TFX)|MMSI - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Envista Holdings Corp NVST|ICUI: Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan XRAY|LMAT (LeMaitre Corp) - Multiplikator EV/Sales|ATRC (AtriCure Inc) - Koefisien nilai perusahaan marang pendapatan|Multiplikator EV/Sales STAA|NAGE (ChromaDex Corp) - Nilai bisnis marang pendapatan|ZimVie Inc. - Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan angiodynamics.com (ANGO)|CERS - Rasio nilai perusahaan marang pendapatan|TKNO - Multiplikator EV/Sales|Monogram Technologies Inc (MGRM) - Rasio nilai perusahaan marang pendapatan|STSS - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan InfuSystem Holdings, Inc.|Multiplikator nilai perusahaan marang pendapatan Utah Medical Products UTMD|Multiplikator EV/Sales KRMD|Rasio total nilai perusahaan marang pendapatan Nyxoah, S.A.|Microbot Medical Inc - Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Pro-Dex Inc. (PDEX)|Zentek - Multiplikator EV/Sales|Elutia (ELUT) - Nilai perusahaan marang pendapatan|Milestone Scientific Inc (MLSS) - Rasio nilai perusahaan marang pendapatan|Retractable Technologies - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan harvardbioscience.com|Femasys Corp (FEMY) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales MHUA|Predictive Oncology Inc. - Rasio nilai perusahaan marang pendapatan|Multiplikator EV/Sales CJMB (Callan JMB Inc)|Multiplikator EV/Sales Atrion Corp ATRI|NeuroMetrix Corporation - Multiplikator EV/Sales